Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Prevalence of major side effects of empagliflozin in the study and placebo groups.
| Adverse Effect | Anker SD et al. [44] | Zinman et al. [43] | ||
|---|---|---|---|---|
| Empagliflozin Group | Placebo | Empagliflozin Group | Placebo | |
| Hypotension | 176/1863 | 163/1863 | - | - |
| 9.45% | 8.75% | |||
| Confirmed hypoglycemia | 33/1863 | 35/1863 | 1303/4684 | 650/2333 |
| 1.77% | 1.88% | 27.80% | 27.80% | |
| Urinary tract infection | 91/1863 | 83/1863 | 842/4684 | 423/2333 |
| 4.88% | 4.46% | 17.97% | 18.12% | |
| Acute renal failure | 175/1863 | 192/1863 | 246/4684 | 155/2333 |
| 9.39% | 10.3% | 5.25% | 6.64% | |
